Nebulizers - Medical Devices Pipeline Assessment, 2019
April 2019
48
About the Report
About the Report
Nebulizers-Medical Devices Pipeline Assessment, 2019
Summary
GlobalData's Medical Devices sector report, Nebulizers-Medical Devices Pipeline Assessment, 2019" provides an overview of Nebulizers currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Nebulizers pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Nebulizers under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Nebulizers and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry.
Reasons to buy
The report enables you to-
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Nebulizers under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date.
Products
Products
Ablynx NV, Customised Infant Inhalation Device; Aeon Research &; Technology, LYNX Nebulizer; AFT Pharmaceuticals Ltd , NasoSURF; Aura Medical, Nebican; Baby's Breath Ltd., WiseAir; Creare LLC, DDC-Based Nebulizer; DesignWise Medical Inc (Inactive), Self-Contained Nebulizer System; Marquette University, Human Powered Nebulizer; Parion Sciences Inc, tPAD Device; SolAeroMed Inc, S1226 Neublizer System; Stirling Pharma Inc, High Density Aerosol Drug Delivery Device; University of California San Diego, Nebulizer; University of Texas Medical Branch at Galveston, Pulse Drug Nebulization System; Verona Pharma Plc, RPL554 Nebulizer; Vincent Medical Holdings Ltd, Home Use Ultrasonic Nebulizer
Companies
Ablynx NV
Aeon Research & Technology
AFT Pharmaceuticals Ltd
Aura Medical
Baby's Breath Ltd.
Creare LLC
DesignWise Medical Inc
Marquette University
Parion Sciences Inc
SolAeroMed Inc
Stirling Pharma Inc
University of California San Diego
University of Texas Medical Branch at Galveston
Verona Pharma Plc
Vincent Medical Holdings Ltd
Table of Contents
Table of Contents
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Nebulizers Overview
3 Products under Development
3.1 Nebulizers-Pipeline Products by Stage of Development
3.2 Nebulizers-Pipeline Products by Segment
3.3 Nebulizers-Pipeline Products by Territory
3.4 Nebulizers-Pipeline Products by Regulatory Path
3.5 Nebulizers-Pipeline Products by Estimated Approval Date
3.6 Nebulizers-Ongoing Clinical Trials
4 Nebulizers-Pipeline Products under Development by Companies
4.1 Nebulizers Companies-Pipeline Products by Stage of Development
4.2 Nebulizers-Pipeline Products by Stage of Development
5 Nebulizers Companies and Product Overview
5.1 Ablynx NV Company Overview
5.2 Aeon Research & Technology Company Overview
5.3 AFT Pharmaceuticals Ltd Company Overview
5.4 Aura Medical Company Overview
5.5 Baby's Breath Ltd. Company Overview
5.6 Creare LLC Company Overview
5.7 DesignWise Medical Inc (Inactive) Company Overview
5.8 Marquette University Company Overview
5.9 Parion Sciences Inc Company Overview
5.10 SolAeroMed Inc Company Overview
5.11 Stirling Pharma Inc Company Overview
5.12 University of California San Diego Company Overview
5.13 University of Texas Medical Branch at Galveston Company Overview
5.14 Verona Pharma Plc Company Overview
5.15 Vincent Medical Holdings Ltd Company Overview
6 Nebulizers- Recent Developments
6.1 Jul 16, 2018: Vectura Appoints Paul Fry as Chief Financial Officer and Executive Director
6.2 Jun 22, 2018: Owens & Minor Names Timothy P. Connolly as EVP, Operations & Supply Chain-Global Solutions
6.3 Jun 19, 2018: Cardinal Health Foundation Awards Over USD 3 Million to More Than 70 Nonprofit Organizations to Fight the Opioid Epidemic across Appalachia
6.4 Jun 04, 2018: Owens & Minor Appoints Interim Chief Financial Officer, as well as a Chief Accounting Officer
6.5 Jun 01, 2018: Vectura Group Appoints Anne Whitaker As Non-Executive Director
6.6 May 31, 2018: Copley Scientific releases new accessories for testing nebulisers with facemasks
6.7 May 29, 2018: Savara Provides Update on Case Reports of Inhaled Granulocyte-Macrophage Colony Stimulating Factor for the Treatment of Nontuberculous Mycobacteria Infection
6.8 May 24, 2018: OMRON Healthcare invests RUSD 60 million to build a new plant in Jundia
6.9 May 14, 2018: Henry Ford Neurosurgeon and Epilepsy Expert Named President of National Pain Management Advocacy Group
6.10 May 11, 2018: Teleflex: Reaffirms 2018 Guidance and Provides 3-Year Financial Goals and Objectives
6.11 May 03, 2018: Cardinal Health Announces Third-quarter Results for Fiscal Year 2018
6.12 May 03, 2018: Teleflex Reports First Quarter 2018 Results
6.13 Apr 25, 2018: Boehringer Ingelheim has a very successful 2017 financial year
6.14 Apr 20, 2018: Vectura Announces Senior Management Change
6.15 Apr 20, 2018: Vectura Group: Directorate Change-Chief Financial Officer
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer
List of Figure
1.2 List of Figures
Figure 1: Nebulizers-Pipeline Products by Stage of Development
Figure 2: Nebulizers-Pipeline Products by Segment
Figure 3: Nebulizers-Pipeline Products by Territory
Figure 4: Nebulizers-Pipeline Products by Regulatory Path
Figure 5: Nebulizers-Pipeline Products by Estimated Approval Date
Figure 6: Nebulizers-Ongoing Clinical Trials
List of Table
1.1 List of Tables
Table 1: Nebulizers-Pipeline Products by Stage of Development
Table 2: Nebulizers-Pipeline Products by Segment
Table 3: Nebulizers-Pipeline Products by Territory
Table 4: Nebulizers-Pipeline Products by Regulatory Path
Table 5: Nebulizers-Pipeline Products by Estimated Approval Date
Table 6: Nebulizers-Ongoing Clinical Trials
Table 7: Nebulizers Companies-Pipeline Products by Stage of Development
Table 8: Nebulizers-Pipeline Products by Stage of Development
Table 9: Ablynx NV Pipeline Products & Ongoing Clinical Trials Overview
Table 10: Customised Infant Inhalation Device-Product Status
Table 11: Customised Infant Inhalation Device-Product Description
Table 12: Aeon Research & Technology Pipeline Products & Ongoing Clinical Trials Overview
Table 13: LYNX Nebulizer-Product Status
Table 14: LYNX Nebulizer-Product Description
Table 15: AFT Pharmaceuticals Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 16: NasoSURF-Product Status
Table 17: NasoSURF-Product Description
Table 18: AFT Pharmaceuticals Ltd-Ongoing Clinical Trials Overview
Table 19: NasoSURF-A Single Center, Randomized, Controlled, Four Way Cross-over Clinical Study Investigating the Deposition of Aerosol Generated by the Nasal Mesh Nebulizer (NMN) Prototype into the Nasal Cavity Using Radio-labelled Saline at Different Pulse Frequency in Healthy Volunteers
Table 20: Aura Medical Pipeline Products & Ongoing Clinical Trials Overview
Table 21: Nebican-Product Status
Table 22: Nebican-Product Description
Table 23: Baby's Breath Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table 24: WiseAir-Product Status
Table 25: WiseAir-Product Description
Table 26: Creare LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 27: DDC-Based Nebulizer-Product Status
Table 28: DDC-Based Nebulizer-Product Description
Table 29: DesignWise Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 30: Self-Contained Nebulizer System-Product Status
Table 31: Self-Contained Nebulizer System-Product Description
Table 32: Marquette University Pipeline Products & Ongoing Clinical Trials Overview
Table 33: Human Powered Nebulizer-Product Status
Table 34: Human Powered Nebulizer-Product Description
Table 35: Parion Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 36: tPAD Device-Product Status
Table 37: tPAD Device-Product Description
Table 38: SolAeroMed Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 39: S1226 Neublizer System-Product Status
Table 40: S1226 Neublizer System-Product Description
Table 41: Stirling Pharma Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 42: High Density Aerosol Drug Delivery Device-Product Status
Table 43: High Density Aerosol Drug Delivery Device-Product Description
Table 44: University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview
Table 45: Nebulizer-Product Status
Table 46: Nebulizer-Product Description
Table 47: University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview
Table 48: Pulse Drug Nebulization System-Product Status
Table 49: Pulse Drug Nebulization System-Product Description
Table 50: Verona Pharma Plc Pipeline Products & Ongoing Clinical Trials Overview
Table 51: RPL554 Nebulizer-Product Status
Table 52: RPL554 Nebulizer-Product Description
Table 53: Vincent Medical Holdings Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 54: Home Use Ultrasonic Nebulizer-Product Status
Table 55: Home Use Ultrasonic Nebulizer-Product Description
Table 56: Glossary
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.